The Lancet Regional Health - Western Pacific · 2021 · 103 citations · 21 references
Public HealthHealth PolicyEpidemiologyHealth EquityHealth Services ResearchHealth DisparitiesHealth Outcomes MeasurementHuman HealthPandemic ResponseSocioeconomic Determinants Of HealthUniversal Health CoverageHealth Outcome DisparitiesHousehold Socioeconomic StatusPopulation Health EquityPublic Health DisparitiesSocioeconomic Access DisparitiesSocioeconomic Disparities In CoverageSocioeconomic Health DisparitiesUniversal Health Coverage Evaluation
BACKGROUND: During the COVID-19 pandemic, South Korea has achieved perfect universal health coverage (UHC)-all Koreans receive UHC regardless of their socioeconomic status. The current study investigated whether socioeconomic disparities remained in COVID-19 health outcomes under UHC. METHODS: This retrospective, observational study included all 7,590 confirmed COVID-19 patients in South Korea up to 15 May 2020. We used the official medical claim database, and socioeconomic status was estimated by insurance type (National Health Insurance Service [NHIS] beneficiaries and Medical Aid [MA] recipients). Type of insurance is a well-known indicator of socioeconomic status. Prevalence (per one million), mortality rate (per one million), and case fatality rate were calculated. To determine the factors associated with case fatality rate, multivariable logistic regressions were performed. FINDINGS: The nationwide prevalence, mortality rate, and case fatality rate of COVID-19 was 144•4, 4•3 and 3•0%, respectively. MA recipients had higher prevalence (424•3 vs 136.3), mortality rate (28•3 vs 3•6), and case fatality rate (6•7 vs 2•7) than NHIS beneficiaries. However, the adjusted analysis showed that the type of insurance was not associated with higher odds of case fatality. INTERPRETATION: We found socioeconomic disparities in COVID-19 prevalence and fatality despite UHC. However, disparities in fatality were not due to socioeconomic status, but due to the poor underlying health conditions of the people. This result can be explained by a combination of UHC, rapid early testing and treatment, transmission-reducing behaviours, and regional preparedness. FUNDING: This research did not receive any funding.
21
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang, Yeming Wang, Xingwang Li et al. · The Lancet · 2020 · 51.8K citations · Full text
Clinical Characteristics of Coronavirus Disease 2019 in China
Wei‐jie Guan, Zhengyi Ni, Yu Hu et al. · New England Journal of Medicine · 2020 · 31.2K citations · Full text
Veterinary Medicine, Infectious Diseases, Internal Medicine +10
COVID-19 and Racial/Ethnic Disparities
Monica Webb Hooper, Anna María Nápoles, Eliseo J. Pérez‐Stable · JAMA · 2020 · 2.2K citations · Full text
COVID-19 and African Americans
Clyde W. Yancy · JAMA · 2020 · 2.1K citations